Skip to main content

Published locations for No benefit with adjuvant sorafenib in intermediate-/high-risk RCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. No benefit with adjuvant sorafenib in intermediate-/high-risk RCC

User login

  • Reset your password
  • /content/no-benefit-adjuvant-sorafenib-intermediate/high-risk-rcc
  • /oncologypractice/article/230969/renal-cell-carcinoma/no-benefit-adjuvant-sorafenib-intermediate/high
  • /hematology-oncology/article/230969/renal-cell-carcinoma/no-benefit-adjuvant-sorafenib-intermediate